Join
Live feed
·
INSIDERFilingvia Quantisnow
Traws Pharma Inc. logo

Director Cautreels Werner was granted 4,874 shares, increasing direct ownership by 5% to 109,222 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRAW (Traws Pharma Inc.) and more on Quantisnow.